CRNX - Crinetics Pharmaceuticals gains amid pitch at Sohn charity conference
2024-04-03 11:37:09 ET
More on Crinetics Pharmaceuticals
- Crinetics: Paltusotine's Phase 3 Triumph Transforms Trajectory (Rating Upgrade)
- Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2023 Earnings Call Transcript
- Crinetics gains as late-stage trial for lead drug succeeds
- Crinetics reports encouraging Phase 2 data for carcinoid syndrome drug
- Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals